Kidney organoids from human pluripotent stem cells (hPSCs) can provides potentials in the modeling of renal diseases, drug screening, nephrotoxicity test of compounds and regenerative therapy. Rgenorgano Biothechnology is a company for developing new therapy for kidney diseases based on technologies for kidney organoids. In this session, I will introduce Rgenorgano Biothechnology as a R&D company in Nephrology.